PDS Biotechnology Corp — Director's Dealing 2020

Nov 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2020-11-03

Reporting Person: BRAWLEY OTIS W (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-03	Stock Option (Right to Buy)	$2.09	A	9000	Acquired	2030-11-03	Common Stock (9000)	Direct

Footnotes

F1: One-third (1/3) of the shares underlying the option shall vest upon each of the first, second and third anniversaries of the date of grant, such that the option will be fully vested on November 3, 2023.